Showing results (1-10 of 77) with videos related to
Sort By:
Pageof 8
Diabetes, Obesity & Metabolism|January 6, 2011
Therapies for diabetic dyslipidaemiaD S H Bell, F Al Badarin, J H O'KeefeDiabetes, Obesity & Metabolism|December 31, 2013
Is statin-induced diabetes clinically relevant? A comprehensive review of the literatureD S H Bell, J J DiNicolantonio, J H O'KeefeDiabetes, Obesity & Metabolism|September 28, 2012
Combine and conquer: advantages and disadvantages of fixed-dose combination therapyD S H BellDiabetes, Obesity & Metabolism|October 14, 2011
Beware the low urine pH--the major cause of the increased prevalence of nephrolithiasis in the patient with type 2 diabetesD S H BellDiabetes, Obesity & Metabolism|May 17, 2011
Why does quick-release bromocriptine decrease cardiac events?D S H BellDiabetes, Obesity & Metabolism|December 22, 2005
Long-term glycaemic efficacy and weight changes associated with thiazolidinediones when added at an advanced stage of type 2 diabetesD S H Bell, F OvalleDiabetes, Obesity & Metabolism|August 4, 2004
Outcomes of initiation of therapy with once-daily combination of a thiazolidinedione and a biguanide at an early stage of type 2 diabetesD S H Bell, F OvalleDiabetes, Obesity & Metabolism|March 5, 2002
Clinical evidence of thiazolidinedione-induced improvement of pancreatic beta-cell function in patients with type 2 diabetes mellitusF Ovalle, D S H BellMayo Clinic Proceedings|June 14, 2000
From Inuit to implementation: omega-3 fatty acids come of ageJ H O'Keefe, W S HarrisExpert Review of Cardiovascular Therapy|August 22, 2006
Frequency of undiagnosed and untreated diabetes mellitus in patients with acute coronary syndromesD G Conaway, J H O'KeefePageof 8